Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of UIC202502 and UIC202505 in Healthy Volunteers
NCT07162441Phase 1Recruiting
- Sponsor
- Korea United Pharm Inc.
- Start
- Aug 2025
- Primary completion
- Sep 2025
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in dyslipidemia (2 arms), sponsored by Korea United Pharm Inc. Primary endpoints: Area Under the Concentration-Time Curve over the Dosing Interval and Maximum Plasma Concentration at Steady State. Started Aug 2025; status: recruiting.
02
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT07162441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07162441.